Home > Centers Overview > DRTC - Johns Hopkins University/University of Maryland
DRTC - Johns Hopkins University/University of Maryland
Baltimore, MD
[WEBSITE]

Investigators from University of Maryland and the Johns Hopkins University have joined together to create the Baltimore Diabetes Research and Training Center (DRTC). The Center fosters collaborative, multidisciplinary diabetes and endocrinology research, and translates that research into programs to train health care professionals in the diagnosis and management of diabetes.

The Center aims to speed the translation of advances in basic biomedical and genetic research to the clinical arena, where they may be applied to the diagnosis and cost-effective management of diabetes. Finally, the Center seeks to inform others in both professional and lay settings of the accomplishments, opportunities and advancements in diabetes research and training.

Cores

Cell Biology & Image Analysis : The Cell Biology Core will serve as a resource for basic and clinical investigators to study the cellular and molecular pathogenesis of type 1 and type 2 diabetes mellitus..

Prevention & Control : The over-arching mission of the Prevention & Control Core is to understand and reduce health disparities in type 2 diabetes and its complications..

Animal Physiology & Phenotyping : The Integrated Physiology Core will offer to provide service and expertise for a variety of metabolic and endocrine assays, physiological paradigms and monitoring to center..

Transgenic & Gene Modification : The aim of the Transgenic/ES Cell Core will be to accelerate research programs that depend on the development of genetically altered mouse models, including transgenics,..

Molecular Biology, Genomics & Genetics : The purpose of the Genetics Core will be to provide services and support for basic science and clinical investigators that will enhance our understanding of the molecular..

Clinical Investigation & Informatics : The DRTC Clinical Investigation Core (CIC) will serve as the central resource to facilitate the conduct of clinical investigation in diabetes and predisposing associated..

People

Fredric Wondisford, M.D. : Center Director and Director, Transgenic/ES Cell Core, . Phone: 410-502-5763

Alan Shuldiner, M.D. : Center Co-Director and Director, Clinical Investigation Core, . Phone: 410-706-1623

Mehboob Hussain, M.D. : Director, Cell Biology Core, . Phone: 410-502-5761

Andrew Wolfe, PhD : Director, Integrated Physiology Core, . Phone: 410-502-7916

Gabriele Ronnett, Ph.D. : Co-Director, Integrated Physiology Core, . Phone: 410-614-6482

Sally Radovick, M.D. : Director, Pilot & Feasibility Program and Co-Director, Transgenic/ES Cell Core, . Phone: 410-955-6463

Braxton D Mitchell Jr., Ph.D., M.P.H. : Director, Genetics Core, . Phone: 410-706-0161

Kristi D Silver, M.D. : Co-Director, Genetics Core, . Phone: 410-706-1628

Da-Wei Gong, M.D., Ph.D. : Co-Director, Genetics Core, . Phone: 410-706-1672

Andrew P. Goldberg, M.D. : Director, Clinical Investigation Core, . Phone: 410-605-7183

Frederick Brancati, M.D., MHS : Director, Prevention and Control Core, . Phone: 410-955-9843

Christopher Saudek, M.D. : Co-Director, Prevention and Control Core, . Phone: 410-955-2132